Nova Point Capital, LLC Abbott Laboratories Transaction History

Nova Point Capital, LLC

$291 Million
Q2 2024

A detailed history of Nova Point Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nova Point Capital, LLC holds 30,250 shares of ABT stock, worth $3.12 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

30,250

Previous 28,317 6.83%

Holding current value

$3.12 Million

Previous $3.22 Million 2.33%

% of portfolio

1.08%

Previous 1.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$100.73 - $112.44 $194,711 - $217,346	1,933 Added 6.83%	30,250 $3.14 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $215,097 - $237,565	-1,964 Reduced 6.49%	28,317 $3.22 Million
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $127,348 - $155,884	-1,412 Reduced 4.46%	30,281 $3.33 Million
Q3 2023 Oct 18, 2023	BUY	$95.53 - $114.62 $176,730 - $212,047	1,850 Added 6.2%	31,693 $3.07 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $15,520 - $17,292	-154 Reduced 0.51%	29,843 $3.25 Million

Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $87,561 - $103,065	904 Added 3.11%	29,997 $3.04 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $84,698 - $99,364	891 Added 3.16%	29,093 $3.19 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $5,321 - $6,161	55 Added 0.2%	28,202 $2.73 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $120,952 - $146,193	1,185 Added 4.4%	28,147 $3.06 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $153,014 - $186,591	1,342 Added 5.24%	26,962 $3.19 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $186,812 - $228,740	1,617 Added 6.74%	25,620 $3.61 Million
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $40,131 - $44,396	344 Added 1.45%	24,003 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $74,264 - $87,420	702 Added 3.06%	23,659 $2.74 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $50,501 - $59,498	-464 Reduced 1.98%	22,957 $2.75 Million
Q4 2020 Feb 18, 2021	BUY	$105.0 - $114.42 $388,605 - $423,468	3,701 Added 18.77%	23,421 $2.56 Million
Q3 2020 Oct 27, 2020	SELL	$91.64 - $111.29 $16,770 - $20,366	-183 Reduced 0.92%	19,720 $2.15 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $31,470 - $40,278	411 Added 2.11%	19,903 $1.82 Million
Q1 2020 Jun 18, 2020	BUY	$62.82 - $91.86 $29,336 - $42,898	467 Added 2.45%	19,492 $1.54 Million
Q4 2019 Jun 18, 2020	BUY	$78.51 - $87.4 $1.49 Million - $1.66 Million	19,025 New	19,025 $1.65 Million

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $180B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nova Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nova Point Capital, LLC with notifications on news.

Account

Nova Point Capital, LLC Abbott Laboratories Transaction History